Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-838
Closed -$203K 124
2022
Q1
$203K Buy
+838
New +$193K 0.07% 122
2021
Q3
Sell
-920
Closed -$224K 132
2021
Q2
$224K Buy
920
+2
+0.2% +$492 0.09% 114
2021
Q1
$228K Buy
+918
New +$219K 0.1% 109
2020
Q4
Sell
-925
Closed -$235K 109
2020
Q3
$235K Buy
925
+24
+3% +$5.95K 0.13% 93
2020
Q2
$213K Buy
+901
New +$206K 0.13% 90
2019
Q1
Sell
-140
Closed -$27K 96
2018
Q4
$27K Buy
+140
New +$27.3K 0.02% 234

Other funds holding AMGN

WealthOne's AMGN Position: Q2 2022 in Review

WealthOne sold out of Amgen (AMGN) in Q2 2022, closing a stake of 838 shares — an estimated $203K sold.

WealthOne first reported a position in AMGN in Q4 2018 and held it in 6 quarters. The position peaked at $235K in Q3 2020. 2,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • WealthOne reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • WealthOne sold 838 Amgen shares in Q2 2022, an estimated $203K.
  • WealthOne first reported a position in Amgen in Q4 2018 and held it in 6 quarters.
  • WealthOne's Amgen position peaked at $235K in Q3 2020.
  • 2,353 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on WealthOne's 13F filing for Q2 2022, filed 18 Jul 2022.